Home Newsfeeds Barclays Maintains Equal-Weight on Pfizer, Lowers Price Target to $44

Barclays Maintains Equal-Weight on Pfizer, Lowers Price Target to $44

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $50 to $44.

byBenzinga Newsdesk

October 12, 2022

1 minute read

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $50 to $44.

SYLA Technologies Increases FY23 EPS Guidance From ¥1,359–¥1,637 To ¥2,600

By Benzinga Newsdesk

December 13, 10:26 AM

Updated Financial Guidance for Full Year 2023Revenues are expected to be ¥22,500 million, a reduction from the Previous Guidance of ¥24,700 – ¥26,700 millionIncome from continuing operations (excluding income from the

SYT

Legal
News

‘Lawsuit Filed By Attorney General Matthew Platkin, New Jersey Division Of Consumer Affairs Accuses Five Oil And Gas Companies Of Misleading The Public About Their Products And Climate Change’ – State Of New Jersey | Department Of Law & Public Safety

By Benzinga Newsdesk

October 18, 12:36 PM

Lawsuit Filed by AG, NJDEP, and Division of Consumer Affairs Accuses Five Oil and Gas Companies of Misleading the Public About Their Products and Climate Change - New Jersey Office of Attorney General

Corcept Completes Enrollment In Phase 3 Gradient Trial Of Relacorilant In Patients With Adrenal Cushing’s Syndrome

By Benzinga Newsdesk

April 1, 8:11 AM

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by

CORT

Microsoft Strikes Nware Deal to Woo European Officials Over Activision Acquisition, Lyft Lay-offs Over 1K Employees, Big Oil Earnings: Top Stories For Today

By Vandana Singh

April 28, 10:06 AM

Benzinga

ATVI

Barclays Maintains Equal-Weight on Pfizer, Lowers Price Target to $44

Related Posts

SYLA Technologies Increases FY23 EPS Guidance From ¥1,359–¥1,637 To ¥2,600

‘Lawsuit Filed By Attorney General Matthew Platkin, New Jersey Division Of Consumer Affairs Accuses Five Oil And Gas Companies Of Misleading The Public About Their Products And Climate Change’ – State Of New Jersey | Department Of Law & Public Safety

Corcept Completes Enrollment In Phase 3 Gradient Trial Of Relacorilant In Patients With Adrenal Cushing’s Syndrome

Microsoft Strikes Nware Deal to Woo European Officials Over Activision Acquisition, Lyft Lay-offs Over 1K Employees, Big Oil Earnings: Top Stories For Today